Costco Wholesale Corporation vs Revvity Inc — how do they compare? Costco Wholesale Corporation trades at $948.89 (market cap $418.79B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Costco Wholesale Corporation is far larger — about 32.4× Revvity Inc's market cap, and Costco Wholesale Corporation pays the higher dividend (0.62%). Which is the better fit depends on your goals.
| COST | RVTY | |
|---|---|---|
Market Cap | $418.79B | $12.91B |
Sector | Consumer Staples | Technology |
52-Week High | $1.09K | $117.75 |
52-Week Low | $849.63 | $82.26 |
Enterprise Value | $406.93B | $15.23B |
Dividend Yield | 0.62% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $944.32, down 0.88% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong March sales growth of 11.3% year-over-year (Business Wire, April 8, 2026) and has consistently beaten earnings expectations in recent quarters. Revenue reached $275.24 billion in 2025 with net income of $8.10 billion, though valuation ratios remain elevated with a P/E of 47.5. Analyst consensus is strongly bullish with 65.5% buy ratings and a $1,120 price target.
Costco's outlook remains positive due to membership fee increases and expanding warehouse footprint, but the stock faces risks from high valuation multiples and competitive retail pressures. The current price sits near key support at $938, with upside potential to resistance at $950. Institutional buying activity continues, though technical indicators suggest near-term consolidation may occur before further gains.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Trailing returns across standard periods
Latest headlines on both assets
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →